| Mrs Andrea Kelly Sparrow, LCSW | |
|
130 Kings Daughters Dr, Frankfort, KY 40601-4248 | |
| (502) 617-0937 | |
| (502) 223-7491 |
| Full Name | Mrs Andrea Kelly Sparrow |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 10 Years |
| Location | 130 Kings Daughters Dr, Frankfort, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023191335 | NPI | - | NPPES |
| 7100471300 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 252595 (Kentucky) | Primary |
| Entity Name | Helme Family Counseling |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801166582 PECOS PAC ID: 7911332531 Enrollment ID: O20200108001836 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. today announced that interim results from a large, prospective, observational cohort safety study offer insights into the increased risk of venous thromboembolism (VTE), or blood clots, which is a well-established risk in women who use combination oral contraceptives (COCs), also known as "the Pill".
With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.
Stroke, traumatic injury, and metabolic disorder are major causes of brain damage and permanent disabilities, including motor dysfunction, psychological disorders, memory loss, and more. Current therapy and rehab programs aim to help patients heal, but they often have limited success.
Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.
Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the journal Molecular Cancer Therapeutics.
› Verified 5 days ago
| Entity Name | Andrea Sparrow Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770218737 PECOS PAC ID: 5890178883 Enrollment ID: O20220824002350 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. today announced that interim results from a large, prospective, observational cohort safety study offer insights into the increased risk of venous thromboembolism (VTE), or blood clots, which is a well-established risk in women who use combination oral contraceptives (COCs), also known as "the Pill".
With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.
Stroke, traumatic injury, and metabolic disorder are major causes of brain damage and permanent disabilities, including motor dysfunction, psychological disorders, memory loss, and more. Current therapy and rehab programs aim to help patients heal, but they often have limited success.
Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.
Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the journal Molecular Cancer Therapeutics.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Andrea Kelly Sparrow, LCSW 130 Kings Daughters Dr, Frankfort, KY 40601-4248 Ph: (502) 617-0937 | Mrs Andrea Kelly Sparrow, LCSW 130 Kings Daughters Dr, Frankfort, KY 40601-4248 Ph: (502) 617-0937 |
News Archive
Bayer HealthCare Pharmaceuticals Inc. today announced that interim results from a large, prospective, observational cohort safety study offer insights into the increased risk of venous thromboembolism (VTE), or blood clots, which is a well-established risk in women who use combination oral contraceptives (COCs), also known as "the Pill".
With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.
Stroke, traumatic injury, and metabolic disorder are major causes of brain damage and permanent disabilities, including motor dysfunction, psychological disorders, memory loss, and more. Current therapy and rehab programs aim to help patients heal, but they often have limited success.
Pfizer Inc. today announced that it has received the 2011 Business Civic Leadership Center's Corporate Citizenship Award in the Best International Ambassador category for Pfizer's Global Health Partnerships program.
Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib. The study was published in the journal Molecular Cancer Therapeutics.
› Verified 5 days ago
Ms. Melinda Robin Tucker, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 306 W Main St Ste 512, Frankfort, KY 40601 Phone: 574-546-1900 Fax: 574-546-1999 | |
Susan Buckman, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1030 Burlington Ln Ste 4, Frankfort, KY 40601 Phone: 502-320-3697 | |
Kathryn Elizabeth Ousley, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 207 E Campbell St, Frankfort, KY 40601 Phone: 206-669-3946 | |
Melia Louise Graham, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1604 Louisville Rd, Frankfort, KY 40601 Phone: 844-523-3951 | |
Brandy Stump, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 306 W Main St Ste 512, Frankfort, KY 40601 Phone: 574-546-1900 Fax: 574-546-1999 | |
Melissa Wilson-cassidy, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 Physicians Park, Frankfort, KY 40601 Phone: 910-584-0678 |